Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease

被引：4
|
作者：
Walther, Carl P. [1 ]
Navaneethan, Sankar D. [1 ,2 ]
机构：
[1] Baylor Coll Med, Dept Med, Selzman Inst Kidney Hlth, Nephrol Sect, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Nephrol Sect, Houston, TX USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2017年 / 28卷 / 03期
基金：
美国国家卫生研究院;
关键词：
INHIBITION; ARTHRITIS;
D O I：
10.1681/ASN.2016111173
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：723 / 725
页数：3
相关论文
共 50 条
  • [11] FXR as a novel therapeutic target for vascular disease
    Bishop-Bailey, D
    DRUG NEWS & PERSPECTIVES, 2004, 17 (08) : 499 - 504
  • [12] Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation
    Yang, Zhihong
    Ming, Xiu-Fen
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [13] Selecting the right therapeutic target for kidney disease
    Buvall, Lisa
    Menzies, Robert I.
    Williams, Julie
    Woollard, Kevin J.
    Kumar, Chanchal
    Granqvist, Anna B.
    Fritsch, Maria
    Feliers, Denis
    Reznichenko, Anna
    Gianni, Davide
    Petrovski, Slave
    Bendtsen, Claus
    Bohlooly-Y, Mohammad
    Haefliger, Carolina
    Danielson, Regina Fritsche
    Hansen, Pernille B. L.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [14] Complement, a Therapeutic Target in Diabetic Kidney Disease
    Budge, Kelly
    Dellepiane, Sergio
    Yu, Samuel Mon-Wei
    Cravedi, Paolo
    FRONTIERS IN MEDICINE, 2021, 7
  • [15] Tetrahydrobiopterin: A Vascular Redox Target to Improve Endothelial Function
    Channon, Keith M.
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) : 705 - 708
  • [16] Association Between Vascular Inflammation and Kidney Function in Patients with Rheumatoid Arthritis: Secondary Analysis of TARGET Trial
    Fukui, Sho
    Tawakol, Ahmed
    Winkelmayer, Wolfgang
    Santacroce, Leah
    Giles, Jon
    Liao, Katherine
    Bathon, Joan
    Solomon, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2756 - 2758
  • [17] Endothelial function as a determinant of vascular function and structure: A new therapeutic target
    Gibbons, GH
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (5A): : 3 - 8
  • [18] Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
    Enrica Golia
    Giuseppe Limongelli
    Francesco Natale
    Fabio Fimiani
    Valeria Maddaloni
    Ivana Pariggiano
    Renatomaria Bianchi
    Mario Crisci
    Ludovica D’Acierno
    Roberto Giordano
    Gaetano Di Palma
    Marianna Conte
    Paolo Golino
    Maria Giovanna Russo
    Raffaele Calabrò
    Paolo Calabrò
    Current Atherosclerosis Reports, 2014, 16
  • [19] Inflammation and ischemic heart disease: The next therapeutic target?
    Vilela, Eduardo M.
    Fontes-Carvalho, Ricardo
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2021, 40 (10) : 785 - 796
  • [20] Inflammation and Huntington's disease - a neglected therapeutic target?
    Field, Sophie E.
    Curle, Annabel J.
    Barker, Roger A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (05) : 451 - 467
12345